Trial intelligence / Profile preview

Sufentanil versus fentanyl for postoperative pain in urgent laparoscopic cholecystectomy

2026-525783-18-00Phase 3Authorised

Sponsor
Fundación Biomédica Galicia Sur
Start
Jun 2026
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of sufentanil and fentanyl in acute cholecystitis (2 arms), sponsored by Fundación Biomédica Galicia Sur. Primary endpoint: Visual Analogue Scale (VAS). Planned start Jun 2026; status: authorised.

02

Drugs

sufentanilfentanyl
03

Conditions

acute cholecystitis

Beyond the preview

Go deeper on 2026-525783-18-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2026-525783-18-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call